Mark Powzaniuk

Mark Powzaniuk serves as Chief Business Officer at Molekule Consulting LLC. Molekule Consulting LLC operates in the management consulting sector with approximately 71.0 employees. The company is headquartered in New York, New York. Molekule Consulting LLC generates annual revenue of 4182000.0.

Industry & Role Insights

• • MessageCEO tracks 4,943 executives in the management consulting sector.
• • We have verified contacts for 2 executives at Molekule Consulting LLC.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 GoDaddy Hosting Mobile Friendly Typekit reCAPTCHA Apache Google Tag Manager Bootstrap Framework WordPress.org Remote

pharmaceuticals biotechnology biotech strategic consulting competitive market intelligence strategy consulting medical device medical congress coverage life sciences primary secondary intelligence product portfolio strategy humint strategic intelligence biopharma g2m strategy commercialization due diligence m a intelligence medical devices medical health care business consulting & services biopharmaceutical consulting strategic advisory services human intelligence actionable insights competitive intelligence market access strategies clinical trials optimization regulatory pathways support business insights lifecycle management loss of exclusivity planning discovery & development data-driven insights market positioning go-to-market strategy benchmarking intelligence enterprise-wide intelligence customized reports competitive simulation workshops primary research secondary research conference coverage market landscape assessments real-time intelligence strategic execution therapeutic areas industry best practices commercial success quantitative analysis pharmaceutical strategy global network insider information decision-making support tailored partnerships emerging market intelligence patient access strategies cost of goods sold analysis supply chain logistics mergers & acquisitions support pipeline optimization regulatory landscape assessments client-centered approach deep industry expertise trusted network of sources ethical intelligence gathering advanced analytics ai-driven insights biopharmaceuticals market access ongoing monitoring market assessments ad-hoc projects congress coverage workshops open-source intelligence social intelligence compliance ethical practices industry expertise r&d intelligence emerging markets client partnerships data-driven strategies market dynamics competitor analysis regulatory navigation innovation support healthcare consulting strategic advisory customized solutions client engagement roi-driven outcomes agile operations industry veterans b2b management consulting hospital & health care health wellness & fitness

DA

David Alderman President & CEO at Molekule Consulting LLC

IP

Ian Plant Founding Principal / CEO at 1

RB

Ray Black CEO UK at 1000Steps-Corporate Sales Modelling

AM

Ashish Malik Chief Executive Officer at 108 ideaspace inc.

MC

Manuel Cordon Perez CEO y fundador at 10Code Software Design

How can I contact Mark Powzaniuk?

Mark Powzaniuk's verified email address is available on MessageCEO. They currently work at Molekule Consulting LLC. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Mark Powzaniuk lead?

Mark Powzaniuk is Chief Business Officer at Molekule Consulting LLC, a company in the management consulting sector with 71.0 employees. The company is based in New York, New York.

What industry is Mark Powzaniuk in?

Mark Powzaniuk works in the management consulting industry as Chief Business Officer at Molekule Consulting LLC. MessageCEO provides verified contact information for executives across all major industries.

Is Mark Powzaniuk's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Powzaniuk's profile is kept up-to-date with the latest available information.

Last updated: April 9, 2026